CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


WebEx Physical Activity ProgramWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D013119 Spinal Cord Injuries NIH 0.50

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Improving Activity Engagement Among Persons With SCI During COVID-19

During the current COVID-19 pandemic many spinal cord injury (SCI) rehabilitation services are limited to emergency management, leaving those living in the community without access to services. Unfortunately, this can lead to negative effects including increase in emotional distress, feelings of isolation, and decreased activity engagement. Due to their limited mobility and greater likelihood of respiratory illness it is imperative to provide alternative forms of activity engagement to reduce their risk for secondary complications. Physical activity has been demonstrate to have numerous benefits for individuals with SCI ranging from enhanced health through prevention of secondary complications to improved subjective well-being. The current study proposes to provide an online physical activity program through web-based videoconferencing to person with SCI to improve overall wellbeing and activity engagement. The program will consist of six weeks of twice-weekly, 45-minute sessions in which an experienced fitness instructor (i.e., wheelchair aerobics) with lived experience and a Kinesiology graduate student will lead online sessions. The sessions will be comprised of a 10-minute warm-up phase, a 25-minute aerobic phase and a 10-minute cool-down phase that will incorporate upper-extremity flexibility exercises and guided meditation. In all cases, remote (i.e., in-home) participant monitoring of physiological signals will be conducted by the instructor to ensure safety of participants. Once the program has been completed, participants will be asked to complete self-report questionnaires related to acceptability, feasibility, and limited effectiveness. Participants will also be asked to complete a brief semi-structured interview examining barriers and facilitators of the program. Participant feedback from the interviews will be used to further develop of the program to meet the needs of the population and develop sustainable approaches for access to care in the community setting through collaborations with community partners (SCI Ontario, National SCI Alliance, Ontario Neurotrauma Foundation). Ultimately, the proposed project aims to improve overall wellbeing and access to health care service for those with SCI during the COVID-19 quarantine.

NCT04408287 Spinal Cord Injuries Other: WebEx Physical Activity Program
MeSH:Spinal Cord Injuries

Primary Outcomes

Description: Treatment Satisfaction Questionnaire

Measure: Treatment Satisfaction

Time: 6 weeks

Secondary Outcomes

Description: Spinal Cord Injury - Quality of Life Short Form

Measure: Ability to Participate in Social Roles and Activities

Time: Baseline, 6 weeks, and at 3 month follow-up

Description: Spinal Cord Injury - Quality of Life Short Form

Measure: Fatigue

Time: Baseline, 6 weeks, and at 3 month follow-up

Description: Spinal Cord Injury - Quality of Life Short Form

Measure: Satisfaction with Social Roles and Activities

Time: Baseline, 6 weeks, and at 3 month follow-up

Description: Spinal Cord Injury - Quality of Life Short Form

Measure: Positive Affect and Well-Being

Time: Baseline, 6 weeks, and at 3 month follow-up

Description: Spinal Cord Injury - Quality of Life Short Form

Measure: Pain Interference

Time: Baseline, 6 weeks, and at 3 month follow-up

Description: Spinal Cord Injury - Quality of Life Short Form

Measure: Resilience

Time: Baseline, 6 weeks, and at 3 month follow-up

Description: Spinal Cord Injury - Quality of Life Short Form

Measure: Self-Esteem

Time: Baseline, 6 weeks, and at 3 month follow-up

Other Outcomes

Description: Fear of COVID-19 Scale

Measure: Fear of COVID-19 Scale

Time: Baseline, 6 weeks, and at 3 month follow-up


No related HPO nodes (Using clinical trials)